Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

NCT03688490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-07-01

No results posted yet for this study

Summary

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.

Prospective work based on the distribution of a dedicated questionnaire.

Conditions

  • Myeloproliferative Disorder

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • IANOTTO Jean-Christophe, MD, PhD · Hématologie Clinique-Institut de Cancéro-Hématologie

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-17
Primary Completion
2013-11-04
Completion
2013-11-04

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688490 on ClinicalTrials.gov